PHARMACOKINETICS (PK) OF EDOXABAN, A NOVEL ORAL ANTICOAGULANT (NOAC), WHEN DOSED ALONE OR FOLLOWING SWITCHING FROM DABIGATRAN OR RIVAROXABAN D. Parasrampuria, D. Weilert, J. Maa, L. He,M. Shi,K. BrownCLINICAL PHARMACOLOGY & THERAPEUTICS（2014）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
